Accordingly, the pan-myeloid depletion via colony stimulating factor 1 receptor (CSF1R) blockade increased sensitivity to nilotinib in an in vivo mouse model of BCP-ALL, indirectly confirming the role of non-classical monocytes in the protection of leukemic cells [11]. Here, CSF1R is linked to acute lymphoblastic leukemia.